An optical sensor includes an input part, a fixing part, and a determining part. The input part is provided on the upper side of the sensor. The fixing part on which a carrier is disposed is provided below the input part. The carrier has an acceptor that reacts with an analyte contained in the sample and is fixed on the carrier. The determining part includes a first metal layer, a second metal layer, and a hollow area. The first metal layer is configured to receive an electromagnetic wave. The second metal layer faces the first metal layer. The hollow area is sandwiched between the first metal layer and the second metal layer. The input part, the fixing part, and the hollow area form a part of a passage where the sample flows from the input part to the hollow area.

An optical sensor includes an input part, a fixing part, and a determining part. The input part is provided on the upper side of the sensor. The fixing part on which a carrier is disposed is provided below the input part. The carrier has an acceptor that reacts with an analyte contained in the sample and is fixed on the carrier. The determining part includes a first metal layer, a second metal layer, and a hollow area. The first metal layer is configured to receive an electromagnetic wave. The second metal layer faces the first metal layer. The hollow area is sandwiched between the first metal layer and the second metal layer. The input part, the fixing part, and the hollow area form a part of a passage where the sample flows from the input part to the hollow area.

A device for detecting a chemical species, including a Geiger-mode avalanche diode, which includes a body of semiconductor material delimited by a front surface. The semiconductor body includes: a cathode region having a first type of conductivity, which forms the front surface; and an anode region having a second type of conductivity, which extends in the cathode region starting from the front surface. The detection device further includes: a sensitive structure arranged on the anode region and including at least one sensitive region, which has an electrical permittivity that depends upon the concentration of the chemical species; and a resistive region, arranged on the sensitive structure and electrically coupled to the anode region.

A device for detecting a chemical species, including a Geiger-mode avalanche diode, which includes a body of semiconductor material delimited by a front surface. The semiconductor body includes: a cathode region having a first type of conductivity, which forms the front surface; and an anode region having a second type of conductivity, which extends in the cathode region starting from the front surface. The detection device further includes: a sensitive structure arranged on the anode region and including at least one sensitive region, which has an electrical permittivity that depends upon the concentration of the chemical species; and a resistive region, arranged on the sensitive structure and electrically coupled to the anode region.

A method for determining the total organic carbon in a sample which includes mixing the sample with a reagent containing at least one acid effective for reacting with inorganic carbon-containing materials in the sample, and at least one oxidizing agent effective for oxidizing organic carbon-containing materials in the sample in the presence of ultraviolet radiation, and detecting the carbon dioxide generated, is described. The at least one acid may include phosphoric acid, while the oxidizing agent may include sodium persulfate. In accordance with an embodiment of the inventive concept, the sample is first injected into a reaction chamber, which is continuously flushed with carbon dioxide free gas with no UV light present, and CO.sub.2 generated from any inorganic carbon in the sample as carbonates is flowed through the detector, and may be recorded. Subsequent to this step, the UV light is passed through the reaction chamber and CO.sub.2 generated from the reaction of the at least one oxidizing agent with the organic material in the solution in the presence of ultraviolet radiation, is flowed through the detector, which may be a non-dispersive infrared detector, after the reaction chamber is sparged using a carbon dioxide free gas, and recorded.

A method for determining the total organic carbon in a sample which includes mixing the sample with a reagent containing at least one acid effective for reacting with inorganic carbon-containing materials in the sample, and at least one oxidizing agent effective for oxidizing organic carbon-containing materials in the sample in the presence of ultraviolet radiation, and detecting the carbon dioxide generated, is described. The at least one acid may include phosphoric acid, while the oxidizing agent may include sodium persulfate. In accordance with an embodiment of the inventive concept, the sample is first injected into a reaction chamber, which is continuously flushed with carbon dioxide free gas with no UV light present, and CO.sub.2 generated from any inorganic carbon in the sample as carbonates is flowed through the detector, and may be recorded. Subsequent to this step, the UV light is passed through the reaction chamber and CO.sub.2 generated from the reaction of the at least one oxidizing agent with the organic material in the solution in the presence of ultraviolet radiation, is flowed through the detector, which may be a non-dispersive infrared detector, after the reaction chamber is sparged using a carbon dioxide free gas, and recorded.

An object of the present invention is to provide a highly sensitive immunoanalysis method and analysis apparatus. The invention relates to an analysis method and an analysis apparatus which are constituted in such a way that a component to be measured is reacted with capture component specifically reacting thereto and the reactant is labeled when the component to be measured is present and which are characterized by analyzing the component to be measured with single-molecule sensitivity and resolution by arranging the labeled reactant in a spatially separated certain position and detecting the label of the labeled reactant.

A detection device for cannabinoid use including a base unit and a display screen disposed on the base unit. A central processing unit and a tetrahydrocannabinol testing device are disposed within the base unit. A testing slot is disposed on a bottom portion of the base unit, with a back end of the testing slot disposed within the tetrahydrocannabinol testing device. Each of a plurality of testing strips is slidably and removably disposed within the testing slot. A printer has a pair of T-shaped attachment extensions. Each of the pair of attachment extensions and a universal serial bus plug disposed on the printer simultaneously removably and slidably engages each of a pair of attachment slots and a universal serial bus port disposed on the base unit, respectively. The tetrahydrocannabinol testing device is configured to analyze and calculate the presence and amount of tetrahydrocannabinol in a person's bloodstream.

A detection device for cannabinoid use including a base unit and a display screen disposed on the base unit. A central processing unit and a tetrahydrocannabinol testing device are disposed within the base unit. A testing slot is disposed on a bottom portion of the base unit, with a back end of the testing slot disposed within the tetrahydrocannabinol testing device. Each of a plurality of testing strips is slidably and removably disposed within the testing slot. A printer has a pair of T-shaped attachment extensions. Each of the pair of attachment extensions and a universal serial bus plug disposed on the printer simultaneously removably and slidably engages each of a pair of attachment slots and a universal serial bus port disposed on the base unit, respectively. The tetrahydrocannabinol testing device is configured to analyze and calculate the presence and amount of tetrahydrocannabinol in a person's bloodstream.

Portable devices for anti-drug antibodies (ADAs) testing are provided. These devices can be used in various applications, including but not restricted to the following: uniform testing of patients for ADAs; selection of therapeutic drug for patient treatment; evaluation of the need to change therapeutic drug or to apply tolerance regimens; selection of patients for clinical trials; comparison of therapeutic drugs marketed for a given disease and also gene therapy; scientific guidance for discovering therapeutic drugs; therapeutic drug development; postmarketing surveillance of therapeutic drugs.